The systemic hallmarks of cancer

Doru Paul

DOI: https://doi.org/10.20517/2394-4722.2020.63

2020-08-28

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.

What problem does this paper attempt to address?

Pancreatic cancer: treatment approaches and trends

Nabyla Paixão Pereira,José Raimundo Corrêa

DOI: https://doi.org/10.20517/2394-4722.2018.13

2018-06-25

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery

Yohsuke Yagawa,Keishi Tanigawa,Yasunobu Kobayashi,Masakazu Yamamoto

DOI: https://doi.org/10.20517/2394-4722.2017.35

2017-10-31

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Targeting epithelial-mesenchymal transition - an ongoing wild goose chase

Raveendra B. Mokhamatam,Vamshi K. Irlapati,Subhadra Dravida

DOI: https://doi.org/10.20517/2394-4722.2020.38

2020-08-28

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Embracing cancer complexity: Hallmarks of systemic disease

Charles Swanton,Elsa Bernard,Chris Abbosh,Fabrice André,Johan Auwerx,Allan Balmain,Dafna Bar-Sagi,René Bernards,Susan Bullman,James DeGregori,Catherine Elliott,Ayelet Erez,Gerard Evan,Mark A. Febbraio,Andrés Hidalgo,Mariam Jamal-Hanjani,Johanna A. Joyce,Matthew Kaiser,Katja Lamia,Jason W. Locasale,Sherene Loi,Ilaria Malanchi,Miriam Merad,Kathryn Musgrave,Ketan J. Patel,Sergio Quezada,Jennifer A. Wargo,Ashani Weeraratna,Eileen White,Frank Winkler,John N. Wood,Karen H. Vousden,Douglas Hanahan

DOI: https://doi.org/10.1016/j.cell.2024.02.009

IF: 64.5

2024-03-28

Cell

Abstract:Cancer is a systemic disease in more than one dimension, in terms of its evolutionary course, direct crosstalk with the microenvironment, and intricate communication with the macro-environment. This broad perspective encompasses our understanding of cancer's systemic features, mapping out the path for tackling its complexity to bridge what we can learn and who we need to help.

cell biology,biochemistry & molecular biology
Novel approaches to therapeutics in pancreatic adenocarcinoma: vitamin C and tumor treatment fields

Laith Abushahin,Travis Jones,Jonathan Song,Terence M. Williams,Haseebah Shahzad,Anne Noonan

DOI: https://doi.org/10.20517/2394-4722.2021.02

2021-01-01

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Circulating Tumor Cells: From Basic to Translational Research

Luis Enrique Cortés-Hernández,Zahra Eslami-S,Klaus Pantel,Catherine Alix-Panabières

DOI: https://doi.org/10.1093/clinchem/hvad142

IF: 12.114

2024-01-01

Clinical Chemistry

Abstract:Abstract Background Metastasis is the leading cause of cancer-related deaths. Most studies have focused on the primary tumor or on overt metastatic lesions, leaving a significant knowledge gap concerning blood-borne cancer cell dissemination, a major step in the metastatic cascade. Circulating tumor cells (CTCs) in the blood of patients with solid cancer can now be enumerated and investigated at the molecular level, giving unexpected information on the biology of the metastatic cascade. Content Here, we reviewed recent advances in basic and translational/clinical research on CTCs as key elements in the metastatic cascade. Summary Findings from translational studies on CTCs have elucidated the complexity of the metastatic process. Fully understanding this process will open new potential avenues for cancer therapeutic and diagnostic strategies to propose precision medicine to all cancer patients.

medical laboratory technology
Therapeutic targets against gastric cancer stem cells interacting with tumor microenvironment

Tomoyuki Uchihara,Takatsugu Ishimoto,Atsuko Yonemura,Hideo Baba

DOI: https://doi.org/10.20517/2394-4722.2017.81

2018-02-26

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Liquid biopsy in lymphomas: a potential tool for refining diagnosis and disease monitoring

Riccardo Moia,Chiara Favini,Silvia Rasi,Clara Deambrogi,Valentina Ferri,Mattia Schipani,Sruthi Sagiraju,Abdurraouf Mokhtar Mahmoud,Ahad Ahmed Kodipad,Ramesh Adhinaveni,Andrea Patriarca,Luca Nassi,Gianluca Gaidano

DOI: https://doi.org/10.20517/2394-4722.2019.020

2019-09-04

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
A review on exosome-based cancer therapy

Alex Von Schulze,Fengyan Deng

DOI: https://doi.org/10.20517/2394-4722.2020.79

2020-11-06

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Integrating Hallmarks of Cancer

Clara Salva de Torres,Iosune Baraibar,Nadia Saoudi González,Javier Ros,Francesc Salva,Marta Rodríguez-Castells,Adriana Alcaraz,Ariadna García,Josep Tabernero,Elena Élez

DOI: https://doi.org/10.3390/ijms25136967

IF: 5.6

2024-06-27

International Journal of Molecular Sciences

Abstract:The treatment of unresectable metastatic colorectal cancer has evolved over the last two decades, as knowledge of cancer biology has broadened and new targets have emerged. 'The Hallmarks of Cancer' illustrate the crucial capabilities acquired by cells to become malignant and represent the evolution of knowledge of tumor biology. This review integrates these novel targets and therapies into selected hallmarks: sustaining proliferative signaling, inducing vasculature, avoiding immune destruction, genome instability and mutation, reprogramming cellular metabolism, and resisting cell death. The different strategies and combinations under study are based on treatments with anti-EGFR, anti-VEGF, and anti-HER2 agents, KRAS G12C inhibitors, BRAF and MEK inhibitors, and immune checkpoint inhibitors. However, new approaches are emerging, including vaccines, WEE1 inhibitors, and PARP inhibitors, among others. The further deciphering of cancer biology will unravel new targets, develop novel therapies, and improve patients' outcomes.

biochemistry & molecular biology,chemistry, multidisciplinary
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?

DOI: https://doi.org/10.20517/2394-4722.2022.106

2023-01-01

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.

English Else
Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances

Alessia Pellerino,Valeria Internò,Erminia Muscolino,Francesca Mo,Francesco Bruno,Edoardo Pronello,Federica Franchino,Riccardo Soffietti,Roberta Rudà

DOI: https://doi.org/10.20517/2394-4722.2020.80

2020-10-29

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Photodynamic therapy in cancer treatment - an update review

Anc��ly Ferreira Dos Santos,Daria Raquel Queiroz De Almeida,Leticia Ferreira Terra,Maur��cio S Baptista,Leticia Labriola,Maur��cio S. Baptista

DOI: https://doi.org/10.20517/2394-4722.2018.83

2019-03-29

Journal of Cancer Metastasis and Treatment

Abstract:Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
The Epigenetic Hallmarks of Cancer

Manel Esteller,Mark A. Dawson,Cigall Kadoch,Feyruz V. Rassool,Peter A. Jones,Stephen B. Baylin

DOI: https://doi.org/10.1158/2159-8290.cd-24-0296

IF: 28.2

2024-10-05

Cancer Discovery

Abstract:Cancer is a complex disease in which several molecular and cellular pathways converge to foster the tumoral phenotype. Notably, in the latest iteration of the cancer hallmarks, "nonmutational epigenetic reprogramming" was newly added. However, epigenetics, much like genetics, is a broad scientific area that deserves further attention due to its multiple roles in cancer initiation, progression, and adaptive nature. Herein, we present a detailed examination of the epigenetic hallmarks affected in human cancer, elucidating the pathways and genes involved, and dissecting the disrupted landscapes for DNA methylation, histone modifications, and chromatin architecture that define the disease. Significance: Cancer is a disease characterized by constant evolution, spanning from its initial premalignant stages to the advanced invasive and disseminated stages. It is a pathology that is able to adapt and survive amidst hostile cellular microenvironments and diverse treatments implemented by medical professionals. The more fixed setup of the genetic structure cannot fully provide transformed cells with the tools to survive but the rapid and plastic nature of epigenetic changes is ready for the task. This review summarizes the epigenetic hallmarks that define the ecological success of cancer cells in our bodies.

oncology
Hallmarks of cancer: of all cancer cells, all the time?

Sébastien L. Floor,Jacques E. Dumont,Carine Maenhaut,Eric Raspe

DOI: https://doi.org/10.1016/j.molmed.2012.06.005

2012-09-01

Trends in Molecular Medicine

Abstract:In two landmark articles, Hanahan and Weinberg synthesized into one conceptual framework 'the hallmarks of cancer', a massive amount of information describing the characteristics of a cancer cell. Although this is neither the intention nor the belief of the authors, hallmarks are often interpreted as applying to a canonic cancer cell, or equally to all cells within a cancer. In this article, we clarify the separate concepts of causes, oncogenic events, signal transduction programs, and hallmarks to show that there is no unimodal relation between these concepts but a complex network of interrelations that vary in different cells, between cells, and at different times in any given cell. We consider cancer as an evolving, dynamic, and heterogeneous system, explaining, at least in part, the difficulty of treating cancer and supporting the use of simultaneous, multitarget therapies.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Circulating and Disseminated Tumor Cells: Diagnostic Tools and Therapeutic Targets in Motion

Hongxia Wang,Nikolas H. Stoecklein,Peter P. Lin,Olivier Gires

DOI: https://doi.org/10.18632/oncotarget.12242

2016-01-01

Oncotarget

Abstract:Enumeration of circulating tumor cells (CTCs) in peripheral blood with the gold standard CellSearch (TM) has proven prognostic value for tumor recurrence and progression of metastatic disease. Therefore, the further molecular characterization of isolated CTCs might have clinical relevance as liquid biopsy for therapeutic decision-making and to monitor disease progression. The direct analysis of systemic cancer appears particularly important in view of the known disparity in expression of therapeutic targets as well as epithelial-to-mesenchymal transition (EMT)-based heterogeneity between primary and systemic tumor cells, which all substantially complicate monitoring and therapeutic targeting at present. Since CTCs are the potential precursor cells of metastasis, their in-depth molecular profiling should also provide a useful resource for target discovery. The present review will discuss the use of systemically spread cancer cells as liquid biopsy and focus on potential target antigens.
Targeting metastatic cancer

Karuna Ganesh,Joan Massagué

DOI: https://doi.org/10.1038/s41591-020-01195-4

IF: 82.9

2021-01-01

Nature Medicine

Abstract:Despite recent therapeutic advances in cancer treatment, metastasis remains the principal cause of cancer death. Recent work has uncovered the unique biology of metastasis-initiating cells that results in tumor growth in distant organs, evasion of immune surveillance and co-option of metastatic microenvironments. Here we review recent progress that is enabling therapeutic advances in treating both micro- and macrometastases. Such insights were gained from cancer sequencing, mechanistic studies and clinical trials, including of immunotherapy. These studies reveal both the origins and nature of metastases and identify new opportunities for developing more effective strategies to target metastatic relapse and improve patient outcomes.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis

Claudia Tanja Mierke

DOI: https://doi.org/10.3390/biom14020184

IF: 6.064

2024-02-04

Biomolecules

Abstract:Tumor diseases become a huge problem when they embark on a path that advances to malignancy, such as the process of metastasis. Cancer metastasis has been thoroughly investigated from a biological perspective in the past, whereas it has still been less explored from a physical perspective. Until now, the intraluminal pathway of cancer metastasis has received the most attention, while the interaction of cancer cells with macrophages has received little attention. Apart from the biochemical characteristics, tumor treatments also rely on the tumor microenvironment, which is recognized to be immunosuppressive and, as has recently been found, mechanically stimulates cancer cells and thus alters their functions. The review article highlights the interaction of cancer cells with other cells in the vascular metastatic route and discusses the impact of this intercellular interplay on the mechanical characteristics and subsequently on the functionality of cancer cells. For instance, macrophages can guide cancer cells on their intravascular route of cancer metastasis, whereby they can help to circumvent the adverse conditions within blood or lymphatic vessels. Macrophages induce microchannel tunneling that can possibly avoid mechanical forces during extra- and intravasation and reduce the forces within the vascular lumen due to vascular flow. The review article highlights the vascular route of cancer metastasis and discusses the key players in this traditional route. Moreover, the effects of flows during the process of metastasis are presented, and the effects of the microenvironment, such as mechanical influences, are characterized. Finally, the increased knowledge of cancer metastasis opens up new perspectives for cancer treatment.

biochemistry & molecular biology
Building an Organ-Wide Macroscopic View of Cancer Hallmarks

Suling Liu,Yuan Wang,Jiawen Feng,Zhihua Liu,Shengtao Zhou

DOI: https://doi.org/10.1158/2159-8290.cd-24-0833

IF: 28.2

2024-11-03

Cancer Discovery

Abstract:Summary: Despite an increasingly detailed understanding of cancer hallmarks at molecular or atomic resolution, most studies, however, fall short of investigating the systemic interactions of cancer with the human body. We propose to investigate the hallmarks of cancer from an organ-wide macroscopic view, discuss the challenges in preclinical and clinical research to study the cross-organ regulation of cancer together with potential directions to overcome these challenges, and foresee how this holistic view may be translated into more effective therapies.

oncology
Systemic immunity in cancer

Kamir J. Hiam-Galvez,Breanna M. Allen,Matthew H. Spitzer

DOI: https://doi.org/10.1038/s41568-021-00347-z

IF: 78.5

2021-04-09

Nature Reviews Cancer

Abstract:Immunotherapy has revolutionized cancer treatment, but efficacy remains limited in most clinical settings. Cancer is a systemic disease that induces many functional and compositional changes to the immune system as a whole. Immunity is regulated by interactions of diverse cell lineages across tissues. Therefore, an improved understanding of tumour immunology must assess the systemic immune landscape beyond the tumour microenvironment (TME). Importantly, the peripheral immune system is required to drive effective natural and therapeutically induced antitumour immune responses. In fact, emerging evidence suggests that immunotherapy drives new immune responses rather than the reinvigoration of pre-existing immune responses. However, new immune responses in individuals burdened with tumours are compromised even beyond the TME. Herein, we aim to comprehensively outline the current knowledge of systemic immunity in cancer.

oncology

The systemic hallmarks of cancer

Pancreatic cancer: treatment approaches and trends

Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery

Targeting epithelial-mesenchymal transition - an ongoing wild goose chase

Embracing cancer complexity: Hallmarks of systemic disease

Novel approaches to therapeutics in pancreatic adenocarcinoma: vitamin C and tumor treatment fields

Circulating Tumor Cells: From Basic to Translational Research

Therapeutic targets against gastric cancer stem cells interacting with tumor microenvironment

Liquid biopsy in lymphomas: a potential tool for refining diagnosis and disease monitoring

A review on exosome-based cancer therapy

Integrating Hallmarks of Cancer

Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?

Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances

Photodynamic therapy in cancer treatment - an update review

The Epigenetic Hallmarks of Cancer

Hallmarks of cancer: of all cancer cells, all the time?

Circulating and Disseminated Tumor Cells: Diagnostic Tools and Therapeutic Targets in Motion

Targeting metastatic cancer

Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis

Building an Organ-Wide Macroscopic View of Cancer Hallmarks

Systemic immunity in cancer